The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence of febrile neutropenia with docetaxel plus cyclophosphamide in a university-based breast oncology clinic.
A. Soni
No relevant relationships to disclose
A. Brufsky
No relevant relationships to disclose
R. C. Jankowitz
No relevant relationships to disclose
P. Rastogi
No relevant relationships to disclose
V. G. Vogel
No relevant relationships to disclose
S. Puhalla
No relevant relationships to disclose